X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK vs TTK HEALTHCARE - Comparison Results

MERCK    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK TTK HEALTHCARE MERCK/
TTK HEALTHCARE
 
P/E (TTM) x 55.9 19.3 289.5% View Chart
P/BV x 8.4 2.3 369.5% View Chart
Dividend Yield % 0.4 0.7 55.1%  

Financials

 MERCK   TTK HEALTHCARE
EQUITY SHARE DATA
    MERCK
Dec-17
TTK HEALTHCARE
Mar-18
MERCK/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,3581,458 93.1%   
Low Rs933795 117.3%   
Sales per share (Unadj.) Rs665.0408.7 162.7%  
Earnings per share (Unadj.) Rs56.612.9 439.9%  
Cash flow per share (Unadj.) Rs72.523.6 306.5%  
Dividends per share (Unadj.) Rs15.005.00 300.0%  
Dividend yield (eoy) %1.30.4 295.1%  
Book value per share (Unadj.) Rs441.7164.9 267.9%  
Shares outstanding (eoy) m16.6014.13 117.5%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x1.72.8 62.5%   
Avg P/E ratio x20.287.6 23.1%  
P/CF ratio (eoy) x15.847.6 33.2%  
Price / Book Value ratio x2.66.8 38.0%  
Dividend payout %26.538.9 68.2%   
Avg Mkt Cap Rs m19,01115,916 119.4%   
No. of employees `0001.52.2 68.8%   
Total wages/salary Rs m1,6961,090 155.6%   
Avg. sales/employee Rs Th7,150.02,573.8 277.8%   
Avg. wages/employee Rs Th1,098.7485.7 226.2%   
Avg. net profit/employee Rs Th608.281.0 751.2%   
INCOME DATA
Net Sales Rs m11,0405,776 191.1%  
Other income Rs m24076 316.6%   
Total revenues Rs m11,2795,851 192.8%   
Gross profit Rs m1,376426 323.4%  
Depreciation Rs m264152 173.2%   
Interest Rs m047 0.0%   
Profit before tax Rs m1,352302 448.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1700-   
Tax Rs m583120 486.5%   
Profit after tax Rs m939182 516.8%  
Gross profit margin %12.57.4 169.2%  
Effective tax rate %43.139.7 108.5%   
Net profit margin %8.53.1 270.4%  
BALANCE SHEET DATA
Current assets Rs m7,5232,556 294.3%   
Current liabilities Rs m2,2531,675 134.5%   
Net working cap to sales %47.715.3 313.0%  
Current ratio x3.31.5 218.9%  
Inventory Days Days5233 156.0%  
Debtors Days Days4135 116.0%  
Net fixed assets Rs m1,2401,103 112.4%   
Share capital Rs m166141 117.5%   
"Free" reserves Rs m7,1672,188 327.5%   
Net worth Rs m7,3332,330 314.7%   
Long term debt Rs m07 0.0%   
Total assets Rs m9,9124,073 243.4%  
Interest coverage xNM7.4-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.11.4 78.5%   
Return on assets %9.55.6 168.5%  
Return on equity %12.87.8 164.2%  
Return on capital %20.814.9 139.0%  
Exports to sales %03.0 0.0%   
Imports to sales %00.6 0.0%   
Exports (fob) Rs mNA172 0.0%   
Imports (cif) Rs mNA35 0.0%   
Fx inflow Rs m1,015172 589.9%   
Fx outflow Rs m3,04355 5,517.0%   
Net fx Rs m-2,028117 -1,735.6%   
CASH FLOW
From Operations Rs m537253 212.1%  
From Investments Rs m-476-226 211.1%  
From Financial Activity Rs m-220-72 305.3%  
Net Cashflow Rs m-160-41 387.1%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 3.7 491.9%  
FIIs % 1.0 5.2 19.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 25.8 112.8%  
Shareholders   28,591 12,723 224.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK With:   ALEMBIC LTD  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  WOCKHARDT  SUN PHARMA  

Compare MERCK With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Elections or Game of Thrones: What Excites You More?(Podcast)

As the TV war in Game of Thrones is set to conclude, we in India, are amidst our own battle for power - the 2019 Elections.

Related Views on News

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

More Views on News

Most Popular

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

The Best Trading Strategy in the World(Profit Hunter)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

A Letter to You from India's No. 1 Trader(The 5 Minute Wrapup)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

Election Series: Why 'Liquor' is so Important to the Elections(The 5 Minute Wrapup)

Apr 19, 2019

When elections come around, liquor flows like water and everyone gets drunk with power...what does this mean for liquor stocks? Read one to find out from our very own election trading analyst, Vijay Bhambwani.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

MERCK SHARE PRICE


Apr 26, 2019 (Close)

TRACK MERCK

MERCK - SUN PHARMA COMPARISON

COMPARE MERCK WITH

MARKET STATS